Legal Representation
Attorney
Adrienne L. White
USPTO Deadlines
Next Renewal Deadline
931 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-01-25)
Due Date
January 25, 2028
Grace Period Ends
July 25, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
21 events| Date | Code | Type | Description |
|---|---|---|---|
| Aug 1, 2022 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Jul 8, 2022 | FIMP | P | FINAL DISPOSITION PROCESSED |
| Jul 8, 2022 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
| Apr 25, 2022 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Jan 25, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Nov 9, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Nov 9, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Oct 20, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Oct 1, 2021 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Sep 22, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sep 22, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Sep 22, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| May 24, 2021 | RFNT | P | REFUSAL PROCESSED BY IB |
| May 3, 2021 | RFRR | P | REFUSAL PROCESSED BY MPU |
| May 3, 2021 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| May 1, 2021 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Apr 30, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Apr 29, 2021 | DOCK | D | ASSIGNED TO EXAMINER |
| Apr 20, 2021 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Apr 16, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Apr 15, 2021 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 005
Pharmaceutical preparations for use in respiratory and oncology therapeutic areas; active pharmaceutical ingredients in the nature of therapeutic molecules for medical use
First Use Anywhere:
0
First Use in Commerce:
0
Class 040
Custom manufacture of pharmaceutical preparations and active pharmaceutical ingredients; providing information and consultancy in the field of pharmaceutical preparations manufacturing and active pharmaceutical ingredients manufacturing
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Research and development of pharmaceutical preparations and active pharmaceutical ingredients; quality control and quality management namely quality evaluation and analysis, quality assurance, and quality control, in the field of pharmaceutical preparations and active pharmaceutical ingredients
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
040
042